Risks and benefits of withdrawing cyclosporine from the long-term immunosuppression regimen of heart and heart-lung transplant recipients

MeSH terms

• Adult
• Aged
• Azathioprine / therapeutic use
• Cyclosporine / administration & dosage
• Cyclosporine / adverse effects
• Cyclosporine / therapeutic use*
• Drug Therapy, Combination
• Female
• Follow-Up Studies
• Graft Rejection / epidemiology
• Heart Transplantation / immunology
• Heart Transplantation / physiology*
• Heart-Lung Transplantation / immunology
• Heart-Lung Transplantation / physiology*
• Humans
• Hypertension / epidemiology
• Immunosuppressive Agents / administration & dosage
• Immunosuppressive Agents / adverse effects
• Immunosuppressive Agents / therapeutic use*
• Male
• Methylprednisolone / therapeutic use
• Middle Aged
• Postoperative Complications / epidemiology
• Renal Dialysis
• Retrospective Studies
• Risk Assessment
• Survival Analysis
• Time Factors